| Identification | Back Directory | [Name]
Cyclo(L-alanyl-L-arginyl-L-arginyl-L-cysteinyl-L-tyrosyl-L-asparaginyl-L-α-aspartyl-L-prolyl-L-lysyl-L-cysteinyl-L-seryl-L-α-aspartyl-L-phenylalanyl-L-valyl-L-glutaminyl-L-alanyl-L-α-aspartyl-L-α-glutamyl), cyclic (4→10)-disulfide | [CAS]
1239011-83-6 | [Synonyms]
Mibenratide
Cyclo(L-alanyl-L-arginyl-L-arginyl-L-cysteinyl-L-tyrosyl-L-asparaginyl-L-α-aspartyl-L-prolyl-L-lysyl-L-cysteinyl-L-seryl-L-α-aspartyl-L-phenylalanyl-L-valyl-L-glutaminyl-L-alanyl-L-α-aspartyl-L-α-glutamyl), cyclic (4→10)-disulfide | [Molecular Formula]
C87H129N27O30S2 | [MOL File]
1239011-83-6.mol | [Molecular Weight]
2097.25 |
| Chemical Properties | Back Directory | [density ]
1.61±0.1 g/cm3(Predicted) | [form ]
Solid | [color ]
White to off-white | [Sequence]
Cyclo(Ala-Arg-Arg-Cys-Tyr-Asn-Asp-Pro-Lys-Cys-Ser-Asp-Phe-Val-Gln-Ala-Asp-Glu) (Disulfide bridge:Cys4-Cys10) |
| Hazard Information | Back Directory | [Uses]
Mibenratide, a small cyclic peptide, is an adrenergic β1 receptor antagonist. Mibenratide can be used for heart failure research[1]. | [IC 50]
Beta-1 adrenergic receptor | [References]
[1] Shubhda Dev, et al. Molecular docking analysis of natriuretic peptide receptor-c towards the design of potential atrial fibrillation inhibitors. 2320-7418. |
|
| Company Name: |
YantaiBio
|
| Tel: |
13758194781 15083780366 |
| Website: |
|
|